In the 5-year estimates, patients with high levels of Apo B had a two-fold increased risk of recurrence of their breast cancer versus patients with low levels of Apo B. In contrast, there was no association between Apo A-1 levels and breast cancer outcomes. Here, APOB is linked to breast cancer.